Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity

PHASE3RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Retinopathy of PrematurityDexmedetomidine
Interventions
DRUG

Dexmedetomidine

Intranasal administration of dexmedetomidine will be done using MAD Nasal atomization device (Teleflex Medical, 3015 Carrington Mill Blvd, Morrisville, NC 27560, USA). Administration will be given to both nares at a similar volume.

DRUG

Saline

Intranasal administration of saline 0.9% will be done using MAD Nasal atomization device (Teleflex Medical, 3015 Carrington Mill Blvd, Morrisville, NC 27560, USA). Administration will be given to both nares at a similar volume.

Trial Locations (1)

7033001

RECRUITING

Assaf-Harofeh Medical Center, Be’er Ya‘aqov

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV